197 related articles for article (PubMed ID: 15226340)
21. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Frank M; Klose KJ; Wied M; Ishaque N; Schade-Brittinger C; Arnold R
Am J Gastroenterol; 1999 May; 94(5):1381-7. PubMed ID: 10235222
[TBL] [Abstract][Full Text] [Related]
22. [Octreotide in the treatment of advanced pancreatic tumor. Preliminary study].
Cirillo F; Bottini A; Brunelli A; Zuffada S; Bassi M; Filippini L; Alquati P
Minerva Chir; 1998 Dec; 53(12):979-85. PubMed ID: 10210927
[TBL] [Abstract][Full Text] [Related]
23. Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.
de Keizer B; van Aken MO; Feelders RA; de Herder WW; Kam BL; van Essen M; Krenning EP; Kwekkeboom DJ
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):749-55. PubMed ID: 18210106
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate.
van Vliet EI; van Eijck CH; de Krijger RR; Nieveen van Dijkum EJ; Teunissen JJ; Kam BL; de Herder WW; Feelders RA; Bonsing BA; Brabander T; Krenning EP; Kwekkeboom DJ
J Nucl Med; 2015 Nov; 56(11):1647-53. PubMed ID: 26272813
[TBL] [Abstract][Full Text] [Related]
25. Quality of life of patients with recurrent nasopharyngeal carcinoma treated with nasopharyngectomy using the maxillary swing approach.
Ng RW; Wei WI
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):309-16. PubMed ID: 16549752
[TBL] [Abstract][Full Text] [Related]
26. [Factors affecting quality of life of patients with gastrointestinal cancer].
Chen P; Wang HJ; Zhu L; Jia R; Jian HY
Ai Zheng; 2007 Oct; 26(10):1116-21. PubMed ID: 17927884
[TBL] [Abstract][Full Text] [Related]
27. [New perspectives in diagnosis and therapy of endocrine gastroenteropancreatic (GEP) tumors with somatostatin analogues].
Rubello D; Rufini V; De Carlo E; Martini C; Calcagni ML; Sicolo N; Troncone L; Casara D
Minerva Endocrinol; 2003 Dec; 28(4):259-96. PubMed ID: 14752399
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: results from the Scandinavian Prostate Cancer Group Study 5.
Jønler M; Nielsen OS; Groenvold M; Hedlund PO; Damber L; Hedelin H; Waldén M;
Scand J Urol Nephrol; 2005; 39(1):42-8. PubMed ID: 15764270
[TBL] [Abstract][Full Text] [Related]
29. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.
Kwekkeboom DJ; Teunissen JJ; Bakker WH; Kooij PP; de Herder WW; Feelders RA; van Eijck CH; Esser JP; Kam BL; Krenning EP
J Clin Oncol; 2005 Apr; 23(12):2754-62. PubMed ID: 15837990
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors.
Zandee WT; Brabander T; Blažević A; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; de Herder WW
J Clin Endocrinol Metab; 2019 Apr; 104(4):1336-1344. PubMed ID: 30566620
[TBL] [Abstract][Full Text] [Related]
31. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.
Forrer F; Riedweg I; Maecke HR; Mueller-Brand J
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):334-40. PubMed ID: 18480742
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life: return to baseline after major and minor liver resection.
Martin RC; Eid S; Scoggins CR; McMasters KM
Surgery; 2007 Nov; 142(5):676-84. PubMed ID: 17981187
[TBL] [Abstract][Full Text] [Related]
33. The forearm flap: assessment of functional and aesthetic outcomes and quality of life.
Ciuman R; Mohr C; Kröger K; Dost P
Am J Otolaryngol; 2007; 28(6):367-74. PubMed ID: 17980766
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.
Melis M; Forrer F; Capello A; Bijster M; Bernard BF; Reubi JC; Krenning EP; De Jong M
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):324-33. PubMed ID: 17923824
[TBL] [Abstract][Full Text] [Related]
35. The assessment of quality of life in patients who have undergone surgery for oral cancer: a preliminary report.
Chandu A; Sun KC; DeSilva RN; Smith AC
J Oral Maxillofac Surg; 2005 Nov; 63(11):1606-12. PubMed ID: 16243177
[TBL] [Abstract][Full Text] [Related]
36. The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
Pasieka JL; McEwan AJ; Rorstad O
Surgery; 2004 Dec; 136(6):1218-26. PubMed ID: 15657579
[TBL] [Abstract][Full Text] [Related]
37. Quality of life following surgery for anterior skull base tumors.
Gil Z; Abergel A; Spektor S; Cohen JT; Khafif A; Shabtai E; Fliss DM
Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1303-9. PubMed ID: 14676156
[TBL] [Abstract][Full Text] [Related]
38. Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.
Frilling A; Weber F; Saner F; Bockisch A; Hofmann M; Mueller-Brand J; Broelsch CE
Surgery; 2006 Dec; 140(6):968-76; discussion 976-7. PubMed ID: 17188146
[TBL] [Abstract][Full Text] [Related]
39. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.
Kim YW; Baik YH; Yun YH; Nam BH; Kim DH; Choi IJ; Bae JM
Ann Surg; 2008 Nov; 248(5):721-7. PubMed ID: 18948798
[TBL] [Abstract][Full Text] [Related]
40. Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia.
Blazeby JM; Metcalfe C; Nicklin J; Barham CP; Donovan J; Alderson D
Br J Surg; 2005 Dec; 92(12):1502-7. PubMed ID: 16252311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
